Skip to main content
. 2017 Jun;108(6):518–525. doi: 10.5935/abc.20170089

Table 1.

Simulated treatments and the expected final LDL-c, according to strategies and baseline LDL-c

Strategy Baseline LDL-c Treatment Final LDL-c
S30% < 70 mg/dL (1.8 mmol/L) None = baseline LDL-c
≥ 70 mg/dL 30% LDL-c reduction = baseline LDL-c – 30%
S50% < 70 mg/dL (1.8 mmol/L) None = baseline LDL-c
≥ 70 mg/dL 50% LDL-c reduction = baseline LDL-c – 50%
Starget-100 < 120 mg/dL (3.1 mmol/L) None = baseline LDL-c
≥ 120 mg/dL ≥ 30% LDL-c reduction = baseline LDL-c – 30% or 100 mg/dL (2.6 mmol/L)*
Starget-70 < 84 mg/dL (2.2 mmol/L) None = baseline LDL-c
≥84 mg/dL ≥ 30% LDL-c reduction = baseline LDL-c – 30% or 70 mg/dL (1.8 mmol/L)*
*

The lower value was considered.